Eledon Pharmaceuticals (ELDN) P/E (2014 - 2026)
Eledon Pharmaceuticals (ELDN) P/E from Sep 30, 2014 to Jul 21, 2026. The TTM Eledon Pharmaceuticals (ELDN) P/E is -3.59. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Eledon Pharmaceuticals (ELDN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -3.59 | -404.30% |
| 2025 | 1.18 | -119.17% |
| 2024 | -6.14 | +2731.14% |
| 2023 | -0.22 | -73.67% |
| 2022 | -0.82 | -54.91% |
| 2021 | -1.83 | -83.96% |
| 2020 | -11.40 | +49.98% |
| 2019 | -7.60 | -21.21% |
| 2018 | -9.65 | -141.43% |
| 2017 | 23.28 | -397.77% |
| 2016 | -7.82 | -80.06% |
| 2015 | -39.21 | -83.16% |
| 2014 | -232.92 | N/A |
Comparison Eledon Pharmaceuticals (ELDN) P/E with competitors
Eledon Pharmaceuticals (ELDN) P/E is -3.59.